Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...

Multiple randomized clinical trials and health record studies show that taking metformin during or soon after SARS-CoV-2 infection lowers the risk of long COVID. This makes metformin the first ...

"SK bioscience begins international Phase I/II trial for GBP511 vaccine" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and ...

After infection with the SARS-CoV-2 virus, up to ten percent of those affected in Germany develop Long COVID. The symptoms ...

This article examines the state of public health in the United States in January 2026, detailing mass COVID-19 infection, excess deaths, collapsing vaccination coverage, immune damage and the ...

A 10-second act of kindness on a flight linked an Indian scientist with an elderly Japanese couple, creating an unexpected family bond that crossed borders, cultures and years.

Federal officials in May 2023 declared an end to the national COVID pandemic. But more than 2 years later, a growing body of ...

Kerala's repeated success in containing Nipah virus outbreaks, without a vaccine or specific treatment, stems from rapid ...

A multi-country study of 3,157 Long COVID patients found neurological and mental health symptoms were reported far more ...

Researchers find long COVID brain effects vary by country, suggesting many cases may go underrecognized in lower-resource ...

Ultraviolet Devices Inc. (UVDI), a developer of advanced ultraviolet disinfection technology, has announced that it has ...